Simultaneous Bet/Crebbp/Ep300 Targeting Approach Compared to Single Bet or Crebbp/Ep300 Inhibition in Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology - United Kingdom
doi 10.1002/hon.196_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR Positive Breast Cancer Cell Lines

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

CREBBP/EP300 Bromodomains Are Critical to Sustain the GATA1/MYC Regulatory Axis in Proliferation

Epigenetics and Chromatin
GeneticsMolecular Biology
2018English

CREBBP/EP300 Mutation Is Associated With Poor Outcome in HNSCC and Targetable With Synthetic Cytotoxicity.

2020English

Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Inhibition of EZH2 or BET Suppresses Diffuse Intrinsic Pontine Glioma

Cancer Discovery
Oncology
2017English

CREB Binding Protein (CREBBP; CBP); E1A Binding Protein P300 (EP300; P300); Hypoxia-Inducible Factor 1α (HIF1A; HIF1α)

Science-Business eXchange
2013English

JUNB, DUSP2, SGK1, SOCS1 and CREBBP Are Frequently Mutated in T-Cell/Histiocyte Rich Large B-Cell Lymphoma

Haematologica
Hematology
2018English

Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Multilocus Association of Genetic Variants in MLL, CREBBP, EP300, and TOP2A With Childhood Acute Lymphoblastic Leukemia in Hispanics From Texas

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy